Theravance Inc news

   Watch this stock
Showing stories 1 - 10 of about 101   

Articles published

THRX 13.97 +0.21 (1.53%)
price chart
Why Theravance Inc.'s 22% Drop Isn't What It Appears
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Theravance, Inc. and Theravance Biopharma, Inc. Announce Completion of ...  Marketwired (press release)
Related articles »  
Theravance: 2 Hidden Catalysts Will Boost Sales
Theravance: 2 Hidden Catalysts Will Boost Sales. Oct. 27, 2014 8:55 AM ET | About: Theravance, Inc. (THRX), Includes: AZN, GSK, TBPH by: Early Retiree Subscribers to SA PRO had an early look at this article.
Related articles »  
When Is It Time To Accumulate Theravance?
Theravance (NASDAQ:THRX) has resumed its horrific decline since peaking in July 2014, when the stock was $32.53. It is down at a yearly low, closing recently at $14.27.
Theravance, Inc. Appoints Michael W. Aguiar as President and Chief Executive ...
Mr. Aguiar will replace Rick E Winningham who has resigned as Chief Executive Officer of Theravance effective August 15, 2014. Mr. Winningham will remain Chairman of the Board of Directors of Theravance, Inc. and will transition to full time Chief ...
Theravance's (THRX) CEO Rick Winningham on Q2 2014 Results - Earnings ...  Seeking Alpha (registration)
Related articles »  
Theravance, Inc. Announces May 15 Record Date and June 2 Share Issue Date ...
SOUTH SAN FRANCISCO, CA, May 06, 2014 (Marketwired via COMTEX) -- Theravance, Inc. THRX, +3.85% (the "Company" or "Theravance") has announced the record date of May 15, 2014 for the Company's strategic separation into two independent, ...
Theravance, Inc. (THRX) Announces Record Date for Separation Into Two ...  StreetInsider.com (subscription)
Theravance's (THRX) CEO Rick Winningham on Q1 2014 Results - Earnings ...  Seeking Alpha
Related articles »  
Theravance Inc (THRX): Glaxosmithkline's New Purchase
Glaxosmithkline PLC, a large shareholder at Theravance Inc (NASDAQ:THRX) disclosed today the acquisition of 832,456 shares in the open market at a unit price of $12,786,524.16 on November 4, 2014.
Theravance (THRX) Falls on Wider-than-Expected Loss in Q3  Zacks.com
Theravance Biopharma Announces Positive Results From Phase 1 Proof-of ...  MarketWatch
Related articles »  
Theravance Inc (THRX) Drops 5.82% on November 10
Theravance Inc (THRX) was one of the Russell 2000's biggest losers for November 10 as the stock slid 5.82% to $13.44, a loss of $0.83 per share.
Related articles »  
What GSK's Q3 Results Mean For Theravance
In the reported figures there is little news: Advair is forecast to decline at similar rates as before and Anoro and Breo continue to sell below consensus.
Theravance to Report Third Quarter 2014 Financial Results on October 30, 2014  Marketwired (press release)
Shining on Major News : Comcast Corporation (NASDAQ:CMCSA), Theravance ...  Tech News
Related articles »  
Theravance, Inc. Appoints Theodore J. Witek, Jr. as Senior Vice President ...
SOUTH SAN FRANCISCO, CA, Jul 02, 2014 (Marketwired via COMTEX) -- Theravance, Inc. THRX, +1.53% ("Theravance"), A Royalty Management Company, today announced the appointment of Theodore J. Witek, Jr.
Related articles »  
Theravance, Inc. Appoints Eric d'Esparbes as Senior Vice President and Chief ...
SOUTH SAN FRANCISCO, CA--(Marketwired - Oct 9, 2014) - Theravance, Inc. ( NASDAQ : THRX) today announced the appointment of Eric d'Esparbes as Senior Vice President and Chief Financial Officer.
Theravance Appoints Eric D'Esparbes As CFO  NASDAQ
Related articles »